Xenical (Orlistat 120mg)

Price range: £34.99 through £119.99

Xenical 120mg capsules contain orlistat to block fat absorption and support medical weight loss.
A prescription-only aid for obesity management.
Packaging and branding may differ from image shown.

Clear Start Assessment

Xenical 120mg Capsules contain orlistat, a powerful lipase inhibitor that helps treat obesity and overweight conditions. Designed to complement a reduced-calorie, low-fat diet, Xenical works by blocking fat absorption in the gut.

It is prescribed to adults with a body mass index (BMI) of 30 or higher, or 28 and above in the presence of weight-related comorbidities such as type 2 diabetes, hypertension, or hyperlipidaemia. Xenical is part of a structured weight loss programme supervised by a doctor or healthcare provider.

How It Works

Xenical works locally in the gut by inhibiting gastric and pancreatic lipase, the enzymes that break down dietary fat. Approximately one-third of the fat consumed in a meal is blocked from absorption and excreted undigested in the stool.

As the unabsorbed fat exits the body, the overall calorie intake is reduced, which supports gradual and sustainable weight loss. Xenical does not act on the brain or suppress appetite, making it suitable for those seeking a non-stimulant-based weight loss solution.

Why Choose Xenical

Clinically proven to promote weight loss

Targets dietary fat absorption rather than altering appetite

Helps lower cholesterol and improve glycaemic control

Suitable for long-term use under medical supervision

Can reduce the risk of weight-related complications

With consistent use, many patients lose 5% or more of their initial body weight within the first 3 months, particularly when accompanied by proper lifestyle changes.

Important Note

Patients using Xenical should adhere to a low-fat diet to avoid gastrointestinal side effects such as oily stools, flatulence, and urgency. Take a multivitamin supplement daily, at least 2 hours before or after the dose, to replace fat-soluble vitamins (A, D, E, K).

Do not exceed the prescribed dose. Consult your doctor before combining Xenical with other weight loss treatments or diabetic medications.

Directions

Note: Follow your GP’s instructions closely.

  • Adults: Take 1 capsule (120mg) three times daily with each main meal containing fat

  • Can be taken during the meal or up to 1 hour after

  • Do not take more than 3 capsules per day

Storage:

  • Store below 25°C

  • Keep away from heat and moisture

  • Do not refrigerate or freeze

  • Keep out of sight and reach of children

Ingredients

  • Active Ingredient:

    • Orlistat 120mg

  • Excipients:

    • Sodium starch glycolate

    • Povidone

    • Gelatin (capsule shell)

    • Titanium dioxide (capsule coating)

Side Effects

Common side effects:

  • Oily or fatty stools

  • Flatulence with discharge

  • Abdominal discomfort

  • Urgent or increased bowel movements

Less common/serious:

  • Liver inflammation

  • Pancreatitis

  • Kidney stones

  • Allergic reactions

Report any persistent or concerning symptoms to your doctor.

Warnings

  • Do not use if:

    • You have chronic malabsorption syndrome

    • You are pregnant or breastfeeding

    • You are allergic to orlistat

  • Caution if:

    • You are taking ciclosporin, warfarin, or thyroid medication

    • You have a history of kidney or liver problems

  • Xenical is most effective when combined with a low-fat, calorie-controlled diet. High-fat meals can cause unpleasant gastrointestinal side effects.
  • Xenical is double the strength of Alli and requires a prescription. It offers enhanced fat-blocking effects and is typically used under clinical supervision.
  • Xenical begins to work within 24 to 48 hours of starting treatment by blocking fat absorption. Visible weight loss usually occurs after 2 to 4 weeks with proper diet.
  • No. Xenical is not recommended during pregnancy or while breastfeeding, as it may interfere with nutrient absorption, including fat-soluble vitamins.
  • Xenical is used to aid weight loss in obese patients (BMI ≥30) or overweight individuals (BMI ≥28) with associated risk factors like high blood pressure, cholesterol, or diabetes.